上海信谱生物医药科技

SimpBiotech is a Shanghai-based biotechnology company specializing in mass spectrometry-based high-throughput screening (MS-HTS) for drug discovery. The company utilizes its proprietary SimpHTS platform to identify small molecule candidates for challenging therapeutic targets, including protein-protein interactions and RNA-binding proteins. By integrating high-resolution mass spectrometry with automated workflows and AI-driven data analysis, SimpBiotech accelerates the identification of high-quality hits and leads. The company's business model includes developing an internal pipeline focused on oncology and metabolic diseases, as well as providing discovery services to global pharmaceutical partners. SimpBiotech aims to overcome the limitations of traditional screening methods to unlock novel therapeutic opportunities.